Retreat of international donors and neglect of national governments threatens harm reduction services
At least 25,000 people in the US may now be using PrEP
Affordable Care Act coverage improves chances of viral suppression for Americans with HIV
WHO guidelines recommend universal antiretroviral treatment, PrEP for those at substantial risk
High standards of care associated with reduced mortality risk of patients with HIV
Second UK cost-effectiveness study finds that large PrEP programmes may need drug price cut to be affordable
Increasing levels of engagement with care is key to controlling HIV epidemic in US
Sexual pleasure and HIV prevention
